Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

iThriveMD vs Tryozi

By GLP-1 ScorecardUpdated

iThriveMDFactor scores not reassessed.
Site position #198

Higher score

TryoziFactor scores not reassessed.
Site position #320

Lower score

Score comparison

iThriveMD has the higher recorded score — 66.7/100 to 61.4/100.

iThriveMD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. iThriveMD is a longevity and metabolic-health clinic (physical locations plus telehealth) offering compounded GLP-1 weight loss — semaglutide (from $299/mo) and tirzepatide (from $399/mo), plus microdosing tirzepatide programs — alongside hormone therapy (HRT/TRT), NAD+, peptides, IV therapy, sexual health, and diagnostic lab testing.

Before you choose

Before comparing the headline prices, the iThriveMD review and the Tryozi review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, iThriveMD vs Vyora Wellness and Joey Med vs Tryozi compare each of them with another graded program, and the list of alternatives to iThriveMD ranks the programs closest to iThriveMD on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the WellMedr review covers one graded close to these two, at 63.2/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueTryozi +9
36
45
Dose & formulationEven
64
64
Clinical oversightiThriveMD +15
89
74
Labs & monitoringiThriveMD +39
91
52
FulfillmentTryozi +15
75
90
Contract termsiThriveMD +6
55
49
iThriveMD · top barTryozi · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetriciThriveMDTryozi
WeighScore66.7/10061.4/100
GradeCC
Site position#198#320
Semaglutide$299/mo (starting dose, compounded)$279/mo (compounded)
Tirzepatide$399/mo (starting dose, compounded)$379/mo (compounded)
CoverageCoverage not publishedAll 50 states
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
iThriveMD

Site position #198 · C

Factor scores not reassessed.

Strengths

  • Compounded semaglutide (from $299/mo) and tirzepatide (from $399/mo), plus microdosing tirzepatide programs
  • Lab testing and personalized protocols with a medical team; free initial consultation
  • Very thorough legal/policy suite (Terms, Privacy, EUA, Shipping, Returns, CCPA)
  • Broad longevity menu: hormones (HRT/TRT), NAD+, peptides, IV therapy, sexual health, diagnostics

What to consider

  • Premium pricing — higher than budget compounded-GLP-1 competitors (lowest rates need 'preferred pricing')
  • Headline GLP-1 pricing is 'starting at'; full cost depends on dose and program length
  • Compounding pharmacy partner not named
  • LegitScript certification was not documented on the public pages reviewed
Tryozi

Site position #320 · C

Factor scores not reassessed.

Strengths

  • Names all four of its 503A compounding pharmacies: RedRock, Health Warehouse, Precision Medicine and Triad Rx
  • Price does not increase as your dose increases, stated plainly on the pricing page
  • Full total shown before payment, with the first-month discount and the ongoing rate both visible
  • States plainly that compounded medications are not FDA-approved, a disclosure many competitors omit

What to consider

  • Headline $139 is a first-month half-price offer; the ongoing rate is $279
  • Multi-week plans are billed once as a single upfront charge, not as a lower monthly rate
  • Plans ship every 4 weeks, so a 52-week plan is 13 shipments rather than 12 months
  • No refund policy detail is published on the pricing page itself

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard